INNOPEA® Forte

INNOPEA® Forte is a dietary supplement with palmitoylethanolamide and B group vitamins that contribute to the normal function of the nervous and immune systems, normal psychological function, as well as reducing fatigue and exhaustion.

Thanks to the specific patented formulation INNOPEA® Forte contributes to reducing the intensity of acute pain in tension-type headaches, stimulating the immune system and faster recovery of the body.

In what conditions is the application of the product INNOPEA® Forte recommended?

Why INNOPEA® Forte?

What does INNOPEA® Forte contain?

Active ingredients
1 sachet
Levagen®+
525 mg
out of which palmitoylethanolamide
472.5 mg
Vitamin B1 (thiamine hydrochloride)
0,55 mg
Vitamin B6 (pyridoxine hydrochloride)
0,70 mg
Vitamin B12 (methylcobalamin)
1,25 µg
INNOPEA® Forte 525 mg ≈ Standard PEA 919 mg
Palmitoylethanolamide has a dose-dependent effect during administration.
Higher dose provides for better therapeutic response.

How to use:

Adults: 1 sachet per day. Dissolve the contents of the sachet in a glass of water and drink in the morning or in the evening, or dissolve the contents of the sachet directly in the mouth.

Packaging: 7 sachets with sweetener and raspberry flavor.

Levagen®+

Levagen®+ predstavlja patentiranu formulaciju u čijem sastavu se nalazi palmitoiletanolamid proizveden specijalnom LipiSperse® tehnologijom koja povećava apsorpciju lipofilnih aktivnih supstanci. LipiSperse® „premaz sistemom“ se oblažu molekuli PEA-e čime se smanjuju hidrofobna svojstva i omogućava se:

INNOPEA®Forte 525 mg ≈ Standardna PEA 919 mg
Palmitoiletanolamid ostvaruje dozno-zavistan efekat tokom primene.
Viša doza obezbeđuje bolji terapijski odgovor.
Efikasnost palmitoiletanolamida (Levagen®+) u redukciji intenziteta bola i vremena trajanja akutnih epizoda glavobolje tenzionog tipa u poređenju sa ibuprofenom1

ZAKLJUČAK:

Levagen®+

Levagen®+ is a patented formulation containing palmitoylethanolamide produced by a special LipiSperse® technology that increases the absorption of lipophilic active substances. LipiSperse® “coating system” coats PEA molecules, which reduces hydrophobic properties and enables:

Efficacy of palmitoylethanolamide (Levagen®+) in reducing pain intensity and duration of acute episodes of tension-type headache compared to ibuprofen1

CONCLUSION: